Table 2.
ASCT characteristics
| Characteristic (N = 4) | Median | N (%) |
|---|---|---|
| Pre-ASCT response | – | |
| CR/VGPR | 3 (75) | |
| PR | 1 (25) | |
| Time to transplant from diagnosis (months) | 3.5 (3–5) | – |
| Dose of melphalan (mg/m2) | 200 (190–200) | – |
| Dose of CD34 cells (× 106 /cumm) | 4 (3.28–4.6) | – |
| Days of neutrophil engraftment (days) | 10 days (8–10) | – |
| Days of platelet engraftment (days) | 11 days (10–12) | – |
| Febrile neutropenia | – | 4 (100) |
| Mucositis | – | 4 (100) |
| Oral Mucositis Grade-3/4 | 3/4 | |
| Lower G.I. Mucositis | 3/4 | |
| PRBC units | 2 (0–2) | – |
| PRP units | 10 (6–18) | – |
| Post-ASCT response (at 3 months interval) | – | |
| CR/VGPR | 4 (100) |